There is a report that Azithromycin is far more than an antibiotic. Some may wish to watch an interview with Dr. Michael Lisanti on antibiotics for COVID-19 and cancer. But — without endorsing as “proved” fact — let’s cut to the chase scene: COVID-19 coronavirus is particularly dangerous for the elderly or those with aging-related Read More…
Economics and policy issues
Current oil and commodity prices — U/D, WTI May future, hits MINUS $37 per bbl!
As my personal blog tracker reports: Let me add, a 1-year look: This of course reflects the impact of economic slowdown due to lockdown, but it also implies room for considerable stimulus. END PS: A look at going into depression: A strongly shocked economy can tumble well within the PPF, sticking there for years, as Read More…
BREAKING: After Prof Raoult’s 78 of 80 success ratio test, France approves [Hydroxy?]Chloroquine for Covid-19
France 24, English has the vid: This is a breakthrough of hope for those who may fall victim to the disease. HT, Vivid. I link the Daily Wire report Vivid links, given the onward confirmation: France Officially Sanctions Drug After 78 Of 80 Patients Recover From COVID-19 Within Five Days By Amanda PrestigiacomoDailyWire.com The French Read More…
Why Economics and ID go Hand-in-Hand
In my previous post about Bob Murphy’s support of ID, some people commented that Bob Murphy, being an economist, doesn’t count much in support of ID. However, those comments would be misplaced. Although Bob Murphy did not get into this in this podcast episode, there is actually a direct connection between ID and economics. First Read More…
A note on the value and validity of investors
Thirty years after Communism collapsed in ignominy, it is again fashionable to bash capitalism and the investor classes. The tone of that rhetoric is sufficiently scapegoating to justify a pause here at UD to make a few notes on a case in point. Accordingly, from the “Further” thread: KF, 232: >>the following are further interesting Read More…